VA2019PAdvPRG 0219.indd 2 05/04/19 15...Workshop to meet up and discuss the latest science, and innovations in clinical arrhythmology, cardiac electrophysiology and pacing. As in the

Advance Program

VA2019PAdvPRG 0219.indd 1VA2019PAdvPRG 0219.indd 1 05/04/19 15.4905/04/19 15.49

VA2019PAdvPRG 0219.indd 2VA2019PAdvPRG 0219.indd 2 05/04/19 15.4905/04/19 15.49

1

Dear Colleagues,

We are pleased to invite you to join us in Venice on October 3-5, 2019 at the 16th edition of the International Workshop on Cardiac Arrhythmias, VeniceArrhythmias 2019.

VeniceArrhythmias is a well-established event on the world congress calendar for the cardiac arrhythmia community. Over the past three decades, hundreds of physicians, scientists, allied professionals, and industry partners from all around the world have chosen this prestigious Workshop to meet up and discuss the latest science, and innovations in clinical arrhythmology, cardiac electrophysiology and pacing.

As in the previous editions, the most widely recognized and internationally accredited experts have been appointed to prepare a top-quality scientifi c program to foster the exchange of scientifi c knowledge and research at the highest level.

The scientifi c agenda of VeniceArrhythmias 2019 will cover all the relevant aspects of cardiac arrhythmias, from pathophysiology to diagnosis, prognosis and therapy.

A special feature of the upcoming edition is represented by the wide range of interactive and practical sessions, including debates, case presentations, let’s discuss all together, and prerecorded and live case sessions aimed at engaging the participants and encouraging the young and emerging leaders to be active protagonists of the event.

There will also be special initiatives, like meet the pioneers and coffee time with mentors, designed to offer faculty members and delegates an extraordinary opportunity to share their ideas and visions in a friendly atmosphere and to build professional relationships of great value.

As in the past, we will also have a series of joint sessions and geographic area sessions prepared in conjunction with the most important international societies in the fi eld of Cardiac Electrophysiology and Pacing.

The congress will be held in the prestigious venue of the Giorgio Cini Foundation, on the magnifi cent island of San Giorgio Maggiore, right in front of San Marco Square.

Finally, you will have the possibility to visit and discover the wonderful city of Venice, one of the most evocative locations in the world, where art and history combine with the natural beauty of the place.

We look forward to welcoming you to Venice Arrhythmias 2019! Yours Sincerely,

Antonio Raviele Andrea Natale Sakis ThemistoclakisMD, FEHRA, FESC, FHRS MD, FACC, FESC, FHRS MD

Invitation letter

VA2019PAdvPRG 0219.indd Sez1VA2019PAdvPRG 0219.indd Sez1 05/04/19 15.4905/04/19 15.49

2


3

People and venue


4

People and venue

Congress Venue

Fondazione Giorgio Cini Isola di San Giorgio Maggiore Venice, Italy, www.cini.it


5

Antonio RavieleALliance to Fight Atrialfi brillation - ALFAVenice-Mestre, Italy

Andrea NataleTexas CardiacArrhythmia InstituteSt. David’s Medical CenterAustin, USA

Sakis ThemistoclakisUnit of Electrophysiologyand Cardiac PacingOspedale dell’AngeloVenice-Mestre, Italy

Presidents

Scientifi c Secretariat

Antonio RossilloCardiology DepartmentOspedale San BortoloVicenza, Italy

ALliance to Fight Atrial fibrillation

People and venue


6

Organizing Committee

President Giuseppe Dal Ben, Italy

Members Amin Al-Ahmad, USA Mohamed Bassiouny, USA Cristiano Breda, Italy J. David Burkhardt, USA Robert C. Canby, USA Francesco Caprioglio, Italy Paolo China, Italy Andrea Corrado, Italy Vittorio Dorrucci, Italy G. Joseph Gallinghouse, USA Giuseppe Grassi, Italy Rodney Horton, USA

Francesco Lazzari, ItalyDomenico Mangino, ItalyElena Marras, ItalyLucio Michieletto, ItalyAndrea Natale, USAAntonio Raviele, ItalyFausto Rigo, ItalyAntonio Rossillo, ItalyJavier Sanchez, USAMichele Tessarin, ItalySakis Themistoclakis, ItalyGuerrino Zuin, Italy

People and venue


7

People and venue

A. Al-AhmadAustin,USA

E. AliotVandoeuvre-lès-Nancy,France

J.M. AlmendralMadrid,Spain

A. ArdashevMoscow,Russia

J.J. BaxLeiden,the Netherlands

S. BovedaToulouse,France

J. BrachmannCoburg,Germany

H. CalkinsBaltimore,USA

A.J. CammLondon,UK

R. CappatoRozzano,Italy

L. Di BiaseNew York,USA

I. Efi movWashington,USA

A.E. EpsteinPhiladelphia,USA

B. FreedmanSydney,Australia

F. GiadaNoale,Italy

D.G. BendittMinneapolis,USA

J.J. BlancBrest,France

M.G. BongiorniPisa,Italy

G. BorianiModena,Italy

G.L. BottoMilan,Italy

S.A. ChenTaipei,Taiwan

L. Colín-LizaldeMexico City,Mexico

W. DaviesLondon,UK

T.F. DeeringAtlanta,USA

R. De PontiVarese,Italy

Program Committee


8

M.R. GoldCharleston,USA

R. GopinathannairOverland Park,USA

W. JungVillingen-Schwenningen,Germany

J.M. KalmanMelbourne,Australia

C. KennergrenGothenburg,Sweden

M.F. MárquezMexico City,Mexico

N.F. MarroucheSalt Lake City,USA

S. MittalNew York,USA

A. NataleAustin,USA

Y.S. OhSeoul,South Korea

A. RevishviliMoscow,Russia

R.P. RicciRome,Italy

A. RossilloVicenza,Italy

A.M. RussoCamden,USA

E. SaadRio de Janeiro,Brazil

Y.H. KimSeoul,South Korea

D.R. LakkireddyKansas City,USA

T.C.A. LobbanStratford-upon-Avon,UK

M. LunatiMilan,Italy

F.E. MarchlinskiPhiladelphia,USA

B. OlshanskyIowa City,USA

O. OseroffBuenos Aires,Argentina

E.N. PrystowskyIndianapolis,USA

A. RavieleVenice-Mestre,Italy

M. RefaatBeirut,Lebanon

Program Committee

People and venue


9

R.A. SansaloneBuenos Aires,Argentina

M. ScanavaccaSão Paulo,Brazil

M.M. ScheinmanSan Francisco,USA

S. SharmaLondon,UK

W.K. ShenPhoenix,USA

E.G. VesterDüsseldorf,Germany

P. VijayaramanWilkes-Barre,USA

S. ViskinTel Aviv,Israel

A.A. WildeAmsterdam,the Netherlands

F. ZanonRovigo,Italy

K. ShivkumarLos Angeles,USA

W.G. StevensonNashville,USA

S. ThemistoclakisVenice-Mestre,Italy

N. VarmaCleveland,USA

A. VermaNewmarket,Canada

W. ZarebaRochester,USA

S. ZhangBeijing,China

Program Committee

People and venue


10


11

AAArrhythmia Alliance

AFAAtrial Fibrillation Association

AIACAssociazione Italiana di Aritmologia e Cardiostimolazione

ALFAALliance to Fight Atrial Fibrillation

ANCEAssociazione Italiana Cardiologi Extraospedalieri

ANMCOAssociazione Nazionale Medici Cardiologi Ospedalieri

APHRSAsia Pacifi c Heart Rhythm Society*

ARCAAssociazione Regionale Cardiologi Ambulatoriali

ECASEuropean Cardiac Arrhythmia Society

EURAEurAsian Arrhythmology Association

GIECGruppo Intervento Emergenze Cardiologiche

GITICGruppo Italiano Infermieri di Area Cardiovascolare

IHRSIndian Heart Rhythm Society

ISHNEInternational Society for Holter & Noninvasive Electrocardiology

JHRSJapanese Heart Rhythm Society

KOREAN HRSKorean Heart Rhythm Society

MENA HRSMiddle East and North Africa Heart Rhythm Society

RSSAAll Russian Scientifi c Societies of Arrhythmology, Electrophysiology and Pacing

SADECSociedad Argentina de Electrofi siología Cardíaca

SIC SPORTSocietà Italiana di Cardiologia dello Sport

SMCSociedad Mexicana de Cardiologia

SOBRACSociedade Brasileira de Arritmias Cardíacas

SOMEECSociedad Mexicana de Electrofi siología y Estimulación Cardiaca

STARSSyncope Trust and Refl ex Anoxic Seizures

StopAfi bStopAfi b Association

TAIWAN HRSTaiwan Heart Rhythm Society

WSAWorld Society of Arrhythmias

www.aa-interna�onal.org

Co-sponsored by:

Under the auspices of:

MENA HRS

Endorsements & Auspices

*To be confi rmed

Under the Patronages of:

Comunedi Venezia

Ministero della Salute

Azienda ULSS 3 Serenissima

Cittàmetropolitanadi Venezia


12

People and venue

M. Aboulmaaty / Cairo, EgyptA. Al–Ahmad / Austin, USAC.M. Albert / Boston, USAP. Alboni / Ferrara, ItalyE. Aliot / Vandoeuvre-lès-Nancy, FranceJ.M. Almendral / Madrid, SpainF. Andreotti / Rome, ItalyE. Anter / Boston, USA*E. Arbelo / Barcelona, SpainA. Ardashev / Moscow, RussiaN. Asaad / Doha, Qatar*G. Bagliani / Foligno, ItalyA. Baranchuk / Kingston, Canada M. Barbierato / Venice-Mestre, Italy*M.T. Barrio-López / Madrid, Spain*C. Basso / Padua, ItalyJ.J. Bax / Leiden, the NetherlandsE. Behr / London, UK*D.G. Benditt / Minneapolis, USAS. Benussi / Brescia, ItalyU. Berrettini / Camerino, ItalyA. Berruezo / Barcelona, SpainE. Bertaglia / Padua, ItalyJ.J. Blanc / Brest, France M.G. Bongiorni / Pisa, ItalyR. Bonin-Schnabel / Hamburg, Germany*A. Bonso / Feltre, ItalyG. Boriani / Modena, ItalyG.L. Botto / Milan, ItalyB.J. Boukens / Amsterdam, the NetherlandsS. Boveda / Toulouse, FranceJ. Brachmann / Coburg, GermanyJ. Bradfi eld / Los Angeles, USAM. Brignole / Lavagna, ItalyH. Calkins / Baltimore, USAD.J. Callans / Philadelphia, USAL. Calò / Rome, ItalyD. Calvo Cuervo / Oviedo, Spain*A.J. Camm / London, UKR.C. Canby / Austin, USA*R. Cappato / Rozzano, ItalyF. Caprioglio / Venice-Mestre, Italy*A. Capucci / Ancona, ItalyC. Carbucicchio / Milan, Italy*M. Castellá Pericás / Barcelona, SpainJ.N. Catanzaro / Jacksonville, USA*G. Cavalli / Venice-Mestre, Italy*F. Cecchi / Florence, Italy*Y.M. Cha / Rochester, USA*K.C. Chang / Taichung, TaiwanM.G. Chelu / Salt Lake City, USAS.A. Chen / Taipei, Taiwan G.B. Chierchia / Brussels, Belgium*P. China / Venice-Mestre, Italy*F.P. Chung / Taipei, TaiwanL. Colín Lizalde / Mexico City, Mexico

A. Corrado / Venice-Mestre, Italy*D. Corrado / Padua, ItalyJ.L. Cox / Chicago, USAA.B. Curtis / Buffalo, USAV. Cutaia / Venice-Mestre, Italy*A. Cutolo / Venice-Mestre, Italy*G. Dandamudi / Indianapolis, USAC. De Asmundis / Brussels, BelgiumT.F. Deering / Atlanta, USAP. Defaye / Grenoble, FranceJ.C. Deharo / Marseille, FranceD.G. Della Rocca / Austin, USAA. Dello Russo / Milan, Italy*R. De Ponti / Varese, ItalyL. Di Biase / New York, USAG. Di Pasquale / Bologna, ItalyA. D’Onofrio / Naples, ItalyF. Drago / Rome, ItalyM. Dzeshka / Grodno, BelarusI. Efi mov / Washington, USAC. Ellis / Nashville, USAA.E. Epstein / Philadelphia, USAL. Fauchier / Tours, FranceA. Fedorowski / Malmö, SwedenS. Feigofsky / Carroll, USA B. Freedman / Sydney, AustraliaR. Furlan / Rozzano, ItalyD. Gabrielli / Fermo, ItalyF. Gaita / Turin, Italy*F.C. Garcia / Philadelphia, USAM. Gasparini / Rozzano, Italy*F. Giada / Noale, ItalyM.R. Gold / Charleston, USAJ.R. Gómez-Flores / Mexico City, MexicoR. Gopinathannair / Overland Park, USAG. Grassi / Venice, ItalyM. Grimaldi / Acquaviva delle Fonti, ItalyM.M. Gulizia / Catania, ItalyD. Hachul / São Paulo, BrazilS. Hakmi / Hamburg, GermanyM.H. Hamdan / Madison, USAS.N. Hatem / Paris, FranceR.N.W. Hauer / Utrecht, the NetherlandsM. Hocini / Bordeaux, France*H.H. Hsia / San Francisco, USAC. Hwang / Provo, USAS. Iliceto / Padua, ItalyJ. Jalife / Ann Arbor, USAJ. Jiménez-Candil / Salamanca, Spain*W. Jung / Villingen-Schwenningen, GermanyS. Kääb / Munich, GermanyY.I. Karpenko / Odessa, UkraineD.G. Katritsis / Athens, Greece*C. Kennergren / Gothenburg, SwedenR.A. Kenny / Dublin, IrelandY.H. Kim / Seoul, South Korea

Invited Faculty


13

People and venue

K.H. Kuck / Hamburg, GermanyA. Kutarski / Lublin, PolandD.R. Lakkireddy / Kansas City, USA*F.M. Leonelli / Tampa, USAS. Lévy / Marseille, FranceT. Lewalter / Munich, GermanyT.C.A. Lobban / Stratford-upon-Avon, UKE.T. Locati / Milan, ItalyC. Love / Baltimore, USAM. Lunati / Milan, ItalyB. Maesen / Maastricht, the Netherlands*C. Mahnkopf / Coburg, GermanyJ.M. Mandrola / Louisville, USAD. Mangino / Venice-Mestre, Italy*R. Mantovan / Conegliano, ItalyR. Marazzi / Varese, ItalyF.E. Marchlinski / Philadelphia, USAM.F. Márquez / Mexico City, MexicoN.F. Marrouche / Salt Lake City, USAW.J. McKenna / Doha, Qatar*A. Medeiros Domingo / Dübendorf, SwitzerlandG.F. Michaud / Nashville, USAF. Migliore / Padua, Italy*S. Mittal / New York, USAL. Molina / Mexico City, MexicoC.A. Morillo / Calgary, CanadaC. Napolitano / Pavia, Italy*Y.S. Oh / Seoul, South KoreaB. Olshansky / Iowa City, USAJ. Osca Asensi / Valencia, Spain*F. Ouyang / Hamburg, Germany*J.C. Pachon / São Paulo, BrazilD.L. Packer / Rochester, USAH.N. Pak / Seoul, South KoreaC. Pappone / San Donato Milanese, Italy*S. Parry / Newcastle-upon-Tyne, UKR.S. Passman / Chicago, USAA. Pelliccia / Rome, ItalyV. Pengo / Padua, Italy*M. Perazzolo Marra / Padua, ItalyJ.P. Piccini / Durham, USA*C. Piorkowski / Dresden, GermanyP.G. Postema / Amsterdam, the NetherlandsV. Probst / Nantes, France*A. Proclemer / Udine, ItalyV.Y. Reddy / New York, USA*M.M. Refaat / Beirut, LebanonF. Regoli / Lugano, SwitzerlandA. Revishvili / Moscow, RussiaR.P. Ricci / Rome, ItalyC.A. Rinaldi / London, UK*J. Romero / New York, USAF. Ronco / Venice-Mestre, Italy*R. Rosso / Tel Aviv, IsraelA. Rubboli / Ravenna, Italy*A.M. Russo / Camden, USA

E. Saad / Rio de Janeiro, BrazilS. Saksena / New Brunswick, USA*J.E. Sanchez / Austin, USAP. Sanders / Adelaide, AustraliaP. Santangeli / Philadelphia, USAL. Santini / Rome, ItalyM. Santini / Rome, ItalyI. Savelieva / London, UK*M. Scaglione / Asti, Italy*M. Scanavacca / São Paulo, BrazilM.M. Scheinman / San Francisco, USAF. Schnell / Rennes, France*P.J. Schwartz / Milan, ItalyL. Segreti / Pisa, ItalyP.S. Sharma / Chicago, USAS. Sharma / London, UKR.S. Sheldon / Calgary, Canada W.K. Shen / Phoenix, USAK. Shivkumar / Los Angeles, USA*H. Sievert / Frankfurt, Germany*M. Silvano / Venice-Mestre, Italy*V.A. Snezhitskiy / Grodno, BelarusP. Sommer / Leipzig, GermanyJ.S. Steinberg / Short Hills, USA*W.G. Stevenson / Nashville, USA G.E. Supple / Philadelphia, USAR. Sutton / Monte Carlo, Principality of MonacoA.K. Talib / Tsukuba, JapanC. Tondo / Milan, ItalyM. Tritto / Castellanza, ItalyM.P. Turakhia / Stanford, USAW. Tzou / Aurora, USAA. Ungar / Florence, ItalyR. Valle / Chioggia, ItalyJ.G. van Dijk / Leiden, the NetherlandsE. van Rooij / Utrecht, the Netherlands*N. Varma / Cleveland, USAB.K. Velthuis / Utrecht, the NetherlandsR. Verlato / Camposampiero, ItalyA. Verma / Newmarket, CanadaE.G. Vester / Düsseldorf, GermanyP. Vijayaraman / Wilkes-Barre, USAJ.F. Viles-Gonzalez / Miami, USAD. Viskin / Tel Aviv, IsraelS. Viskin / Tel Aviv, IsraelA.L. Waldo / Cleveland, USAZ.I. Whinnett / London, UKA.A. Wilde / Amsterdam, the NetherlandsF. Zanon / Rovigo, ItalyG. Zanotto / Legnago, ItalyM. Zardini / Parma, Italy*W. Zareba / Rochester, USAM. Zecchin / Trieste, ItalyS. Zhang / Beijing, ChinaG. Zuin / Venice-Mestre, Italy*

Invited Faculty

*To be confi rmed


14


15

General Scientifi c Overview


16

Featured Symposia

Arrhythmogenic hereditary syndromes

October 4 - Consiglio RoomOctober 5 - Consiglio Room

Program Chairs:Sami Viskin / Tel Aviv, IsraelArthur A. Wilde / Amsterdam, the Netherlands

• Brugada syndrome, an electrical disease or a cardiomyopathy

• Long QT syndrome: an update• Arrhythmogenic cardiomyopathy what’s new?• Quinidine therapy: back from exile!

HF, CRT and… more: evolution of technology and impact on the outcome

October 4 - Cipressi RoomOctober 5 - Cipressi Room

Program Chairs:Michael R. Gold / Charleston, USAWerner Jung / Villingen-Schwenningen, Germany

• Controversial indications for CRT• Novel pacing strategies to treat arrhythmias

and heart failure• Non-response to CRT

Lead extraction and device infection 2019 update

October 3 - Cipressi Room

Program Chairs:Maria Grazia Bongiorni / Pisa, ItalyCharles Kennergren / Gothenburg, Sweden

• Lead extraction and device infection: technical and practical aspects

• Lead extraction and device infection: novel aspects


Syncope & collapse: a 2019 summit

October 3 - Photographs RoomOctober 4 - Photographs Room

Program Chairs:David G. Benditt / Minneapolis, USABrian Olshansky / Iowa City, USA

• Vasovagal syncope: mechanisms• Vasovagal syncope: therapy• Syncope due to autonomic dysfunction /

Differentiating syncope from seizure• Syncope in the young and in the elderly:

peculiar aspects• Syncope units and beyond• Let’s discuss together: current guidelines,

diffi culty cases, and future perspectives


17


Symposia

AF management: current issues

October 4 - Cenacolo Room

Program Chairs:Andrea Natale / Austin, USAAntonio Raviele / Venice-Mestre, ItalySakis Themistoclakis / Venice-Mestre, Italy

• AF & HF: recent advances in therapy• AF: Novel / Controversial aspects

AF-Screen International Collaboration Symposium

October 4 - Capriate Room

Program Chairs:Giuseppe Boriani / Modena, ItalyBen Freedman / Sydney, Australia

Antithrombotic therapy for cardiac arrhythmias


Program Chairs:Giuseppe Boriani / Modena, ItalyA. John Camm / London, UK

• Antithrombotic therapy for cardiac arrhythmias: 10 years of DOACs use

• Antithrombotic therapy for cardiac arrhythmias in specifi c clinical settings

Arrhythmias in the elderly


Program Chairs:Hugh Calkins / Baltimore, USAWin-Kuang Shen / Phoenix, USA

• How does advanced age impact care?

Controversial issues in clinical pacing


Program Chairs:Andrew E. Epstein / Philadelphia, USAMaurizio Lunati / Milan, Italy

• Controversial issues in clinical pacing: should I, when should...

How to predict and prevent sudden death in different clinical settings

October 3 - Consiglio Room

Program Chairs:Giovanni Luca Botto / Milan, ItalyEric N. Prystowsky / Indianapolis, USA

• How to predict and prevent sudden death: patients without structural heart disease

• How to predict and prevent sudden death: patients with structural heart disease


18

Core Curricula

His bundle pacing: when something old becomes new


Program Chairs:Pugazhendhi Vijayaraman / Wilkes-Barre, USAFrancesco Zanon / Rovigo, Italy

• His bundle pacing: the fascinating role of physiology in cardiac pacing

Importance of left atrial appendage for the pathophysiology and treatment of AF

October 3 - Capriate RoomOctober 4 - Cenacolo Room

Program Chairs:Rakesh Gopinathannair / Overland Park, USADhanunjaya R. Lakkireddy / Kansas City, USA

• LAA: its role in AF maintenance and thrombus formation

• LAA closure for stroke prevention and hypertension control

Remote monitoring of cardiac arrhythmias/devices


Program Chairs:Suneet Mittal / New York, USARenato P. Ricci / Rome, Italy

• Remote monitoring: current guidelines, value in special clinical settings, future perspectives

Sport & arrhythmias

October 5 - Photographs Room

Program Chairs:Franco Giada / Noale, ItalySanjay Sharma / London, UK

• Cardiovascular assessment of SD risk in young athletes

• Updates in sports cardiology

Update on clinical trials in cardiac arrhythmias


Program Chairs:Luigi Di Biase / New York, USAAtul Verma / Newmarket, Canada

• Published and ungoing clinical trials in cardiac arrhythmias

Value of cardiac imaging in the management of cardiac arrhythmias

October 3 - Consiglio RoomOctober 4 - Cenacolo Room

Program Chairs:Jeroen J. Bax / Leiden, the NetherlandsNassir F. Marrouche / Salt Lake City, USA

• Value of cardiac imaging in the assessment of SD risk and VT treatment

• Value of cardiac imaging in the management of AF

Zoom in on VT ablation

October 3 - Consiglio RoomOctober 4 - Consiglio Room

Program Chairs:Francis E. Marchlinski / Philadelphia, USAKalyanam Shivkumar / Los Angeles, USA

• Improving outcome and understanding of focal VT ablation

• Evolving strategies and techniques for VT mapping and ablation



19

Practical Sessions

Clinical cases: when a procedure becomes a nightmare


Program Chairs:Luigi Di Biase / New York, USAAntonio Rossillo / Vicenza, Italy

• Clinical cases: when a procedure becomes a nightmare - Session 1

• Clinical cases: when a procedure becomes a nightmare - Session 2

Go back to the basic EP


Program Chairs:Melvin M. Scheinman / San Francisco, USAWilliam G. Stevenson / Nashville, USA

• Mechanism and management of supraventricular arrhythmias

• Mechanism and management of VT and AV block

Value of surface ECG in the interpretation of cardiac arrhythmias in 2019: back to the future?“In memoriam of Luigi Padeletti”


Program Chairs:Serge Boveda / Toulouse, FranceRoberto De Ponti / Varese, Italy

International Scientifi c Societies - VA Joint Sessions

AA-VA Joint Session


Program Chairs:A. John Camm / London, UKTrudie C.A. Lobban / Stratford-upon-Avon, UK

• Standard sets in atrial fi brillation: results from International Consortium for Health Outcomes Measurement - ICHOM

APHRS-VA Joint Session


Program Chairs:Jonathan M. Kalman / Melbourne, AustraliaYoung-Hoon Kim / Seoul, South Korea

• Update in non-PV triggers in AF ablation. When it is indicated and how to avoid complications

ECAS-VA Joint Session


Program Chairs:Riccardo Cappato / Rozzano, ItalyWyn Davies / London, UK

• Current status of recently introduced therapies for cardiac arrhythmias management



20

EURA-VA Joint Session


Program Chairs:Andrey Ardashev / Moscow, RussiaIgor Efi mov / Washington, USA

• Hybrid approach to AF treatment

HRS-VA Joint Session


Program Chairs:Thomas F. Deering / Atlanta, USAAndrea M. Russo / Camden, USA

• Controversies in arrhythmia therapy: what are the knowledge gaps?

ISHNE-VA Joint Session

October 4 - Cipressi RoomOctober 4 - Consiglio Room

Program Chairs:Niraj Varma / Cleveland, USAWojciech Zareba / Rochester, USA

• Telemedicine in cardiac arrhythmias• How to reduce the risk of VT in ICD

patients?

Korean HRS-VA Joint Session


Program Chairs:Young-Hoon Kim / Seoul, South KoreaYong-Seog Oh / Seoul, South Korea

• AF ablation: new innovative concept

MENA-VA Joint Session


Program Chairs:Amin Al-Ahmad / Austin, USAMarwan Refaat / Beirut, Lebanon

• Challenging cases in ablation of cardiac arrhythmias

RSSA-VA Joint Session


Program Chair:Amiran Revishvili / Moscow, Russia

• Novel approach to the hybrid treatment of persistent atrial fi brillation

Taiwan HRS-VA Joint Session

October 4 - Consiglio Room

Program Chairs:Shih-Ann Chen / Taipei, TaiwanAndrea Natale / Austin, USA

• Ventricular arrhythmia in West and non-West

WSA-VA Joint session


Program Chairs:Oscar Oseroff / Buenos Aires, ArgentinaShu Zhang / Beijing, China

• Devices recalls. What to do



21

Geographic Area Corners

Argentinean Corner


Program Chairs:Oscar Oseroff / Buenos Aires, ArgentinaRodolfo A. Sansalone / Buenos Aires, Argentina

• Sudden death and ICDs: a regional evaluation

Brazilian Corner


Program Chairs:Eduardo Saad / Rio de Janeiro, BrazilMauricio Scanavacca / São Paulo, Brazil

• Hot topics in 2019... and still controversial! What is the most recent evidence?

French Corner


Program Chairs:Etienne Aliot / Vandoeuvre-lès-Nancy, FranceJean-Jacques Blanc / Brest, France

• Cardiac fi brosis and arrhythmias: from cells to patients

German Corner


Program Chairs:Johannes Brachmann / Coburg, GermanyErnst G. Vester / Düsseldorf, Germany

• How to prevent thrombo-embolic events in AF patients - interventional vs medical strategies

Mexican Corner

October 5 - Consiglio Room Program Chairs:Luis Colín-Lizalde / Mexico City, MexicoManlio F. Márquez / Mexico City, Mexico

• Channelopathies in 2018. Genetics and beyond

Spanish Corner

October 3 - Photographs Room Program Chair:Jesús M. Almendral / Madrid, Spain

• New challenges in AF ablation



22


23

Program at a Glance


24

Program at a Glance

Thursday October 3, 2019

8.30 10.00

Registrations

Time Cenacolo Capriate Cipressi

10.15 11.45

Standard sets in atrial fi brillation: results from International Consortium for Health Outcomes Measurement - ICHOM

LAA: its role in AF maintenance and thrombous formation

Lead extraction and device infection: technical and practical aspects

12.00 13.30

OPENING CEREMONY & WELCOME BUFFET

13.45 15.15

Antithrombotic therapy for cardiac arrhythmias: 10 years of DOACs use

Hot topics in 2019... and still controversial! What is the most recent evidence?

Lead extraction and device infection: novel aspects

Stop and go

15.30 17.00

Antithrombotic therapy for cardiac arrhythmias in specifi c clinical settings

How doeas advanced age impact care?

Device recalls. What to do

Stop and go

17.15 18.45

How to prevent thrombo-embolic events in AF patients -interventional vs medical strategies

Controversies in arrhythmia therapy: what are the knowledge gaps?

Remote monitoring: current guidelines, value in special clinical settings, future perspectives

Featured Symposia

Core Curricula

Geographic Corners

Symposia


25

Program at a Glance

Thursday October 3, 2019

Registrations 8.30 10.00

Photographs Barbantini Consiglio Soffi tto Time

Cardiac fi brosis and arrhythmias: from cells to patients

Allied Professionals How to predict and prevent sudden death: patients without structural heart disease

Oral Communications 10.15 11.45

12.00 13.30

New challenges in AF ablation

How to predict and prevent sudden death: patients with structural heart disease


Stop and go

Published and ungoing clinical trials in cardiac arrhythmias

Allied Professionals Value of cardiac imaging in the assessment of SD risk and VT treatment


Stop and go

Vasovagal syncope: mechanisms

Allied Professionals Improving outcome and understanding of focal VT ablation


Practical Interactive Sessions

Int. Scientifi c Societies-VA Joint Sessions

Allied Professionals

Oral Communications Sessions


26

Program at a Glance

Friday October 4, 2019


8.30 10.00

LAA closure for stroke prevention and hypertension control

Current status of recently introduced therapies for cardiac arrhythmias management

Telemedicine in cardiac arrhythmias

Stop and go

10.15 11.45

AF & HF: recent advances in therapy

AF-Screen International Collaboration Symposium

Stop and go

12.00 13.30

Stop and go

13.45 15.15

AF: Novel / Controversial aspects

Challenging cases in ablation of cardiac arrhythmias

Complex arrhythmias: mapping and ablation

Stop and go

15.30 17.00

Value of cardiac imaging in the management of AF

Clinical cases: when a procedure becomes a nightmare Session1

Controversial indications for CRT

Stop and go

17.15 18.45

Update in non-PV triggers in AF ablation. When it is indicated and how to avoid complications

Clinical cases: when a procedure becomes a nightmare Session 2

Novel pacing strategies to treat arrhythmias and heart failure

Featured Symposia

Core Curricula

Geographic Corners

Symposia


27

Program at a Glance

Friday October 4, 2019


Vasovagal syncope: therapy

Evolving strategies and techniques for VT mapping and ablation


Stop and go

Syncope due to autonomic dysfunction / Differentiating syncope from seizure

Ventricular arrhythmia in West and non-West


Stop and go

12.00 13.30

Stop and go

Syncope in the young and in the elderly: peculiar aspects

How to reduce the risk of VT in ICD patients?


Stop and go

Syncope units and beyond

Brugada syndrome, an electrical disease or a cardiomyopathy


Stop and go

Let’s discuss together: current guidelines, diffi culty cases, and future perspectives

Long QT syndrome: un update







28

Program at a Glance

Saturday October 5, 2019


8.30 10.00

AF ablation: new innovative concept

Value of surface ECG in the interpretation of cardiac arrhythmias in 2019: back to the future?“In memoriam of Luigi Padeletti”

Non-response to CRT

Stop and go

10.15 11.45

Hybrid approach to AF treatment

Mechanism and management of supraventricular arrhythmias

His bundle pacing: the fascinating role of physiology in cardiac pacing

Stop and go

12.00 13.30

Novel approach to the hybrid treatment of persistent atrial fi brillation

Mechanism and management of VT and AV block

Controversial issues in clinical pacing: shoul I, when should...

Featured Symposia

Core Curricula

Geographic Corners

Symposia


29

Program at a Glance

Saturday October 5, 2019


Sudden death and ICDs: a regional evaluation

Arrhythmogenic cardiomyopathy: what’s new?


Stop and go

Cardiovascular assessment of SD risk in young athletes

Quinidine therapy: back from exile!


Stop and go

Updates in sports cardiology

Channelopathies in 2018. Genetics and beyond







30


31

Detailed Scientifi c Program Cenacolo Room


32


Thursday 3 October / 15.30-17.00

SymposiumANTITHROMBOTIC THERAPY FOR CARDIAC ARRHYTHMIAS IN SPECIFIC CLINICAL SETTINGSChairs: G. Boriani / Modena, Italy -A.J. Camm / London, UK

• Is there an upper limit of age to start direct oral anticoagulants in AF?

V. Pengo / Padua, Italy*

• What to do after an intracranial bleeding? When to restart a DOAC?

J. Romero / New York, USA

• Advanced kidney impairment and dialysis: any role for DOACs?

M.P. Turakhia / Stanford, USA

• Antithrombotic treatment in AF patients with dementia: what decision making?

S.A. Chen / Taipei, Taiwan

• NOACs alone or in combination with ASA for treatment of CAD?

F. Andreotti / Rome, Italy


German Corner HOW TO PREVENT THROMBO-EMBOLIC EVENTS IN AF PTS - INTERVENTIONAL VS. MEDICAL STRATEGIESChairs: W. Jung / Villingen-Schwenningen, Germany - S. Saksena / New Brunswick, USA*

• Detection of silent AF and therapeutic consequences. Which is the appropriate tool and when should OAC be started?

J. Brachmann / Coburg, Germany

• Is the LAA-occluder a safe and reliable alternative to OAC in pts at high bleeding risk? Which technique to prefer and how much and how long is platelet inhibition needed?

T. Lewalter / Munich, Germany

• Catheter ablation of AF - for which patients OAC may be stopped after the procedure?

E.G. Vester / Düsseldorf, Germany

• Secondary stroke prevention in patients with cryptogenic stroke - Lessons from randomized trials

B. Freedman / Sydney, Australia*


AA - VA Joint SessionSTANDARD SETS IN ATRIAL FIBRILLATION: RESULTS FROM INTERNATIONAL CONSORTIUM FOR HEALTH OUTCOMES MEASUREMENT - ICHOMChairs: M.M. Gulizia / Catania, Italy -P. Sanders / Adelaide, Australia

• The ICHOM AF project T.C.A. Lobban / Stratford-upon-Avon, UK

• Choice of outcomes A.J. Camm / London, UK

• Patient reported outcomes & quality of life TBD

• Case mix E. Arbelo / Barcelona, Spain


SymposiumANTITHROMBOTIC THERAPY FOR CARDIAC ARRHYTHMIAS: 10 YEARS OF DOACS USEChairs: D. Gabrielli / Fermo, Italy -M.P. Turakhia / Stanford, USA

• DOACs for AF ten years later: time for assessing the implementation in daily practice worldwide

A.J. Camm / London, UK

• Direct oral anticoagulant in the management of patients with AF and ACS: news on

A. Rubboli / Ravenna, Italy*

• AF and valvular bioprosthesis or TAVI: what role for DOACs?

L. Fauchier / Tours, France

• Atrial high rate episodes detected in an implanted device: what signifi cance? What treatment?

G. Boriani / Modena, Italy

• Early detection of cancer as a consequence of bleeding during antithrombotic therapy: a new perspective

G. Di Pasquale / Bologna, Italy

* To be confi rmed


33


Friday 4 October / 13.45-15.15

SymposiumAF: NOVEL / CONTROVERSIAL ASPECTSChairs: R. Mantovan / Conegliano, Italy - A.M. Russo / Camden, USA

• Obesity as an independent risk factor for AF: is the evidence strong enough?

P. Sanders / Adelaide, Australia

• What is the most common cause of death in patients with AF: stroke, HF or non-CV cause?

I. Savelieva / London, UK*

• Should TEE be performed in all patients undergoing AF ablation to rule out LA thrombus?

E. Bertaglia / Padua, Italy

• Does ablation indexes really increase effi cacy and safety of AF ablation?

G. Cavalli / Venice-Mestre, Italy*


Core CurriculumVALUE OF CARDIAC IMAGING IN THE MANAGEMENT OF AF Chairs: C. Mahnkopf / Coburg, Germany - N.F. Marrouche / Salt Lake City, USA

• Should echocardiography be systematically used in the decision making of OAC treatment in AF patients?*

V. Cutaia / Venice-Mestre, Italy*

• Value of MRI for the management of AF patients

M.G. Chelu / Salt Lake City, USA

• Can imaging select candidates for AF ablation?

J.J. Bax / Leiden, the Netherlands

• Real time MRI for AF ablation P. Sommer / Leipzig, Germany


Core CurriculumLAA CLOSURE FOR STROKE PREVENTION AND HYPERTENSION CONTROLChairs: F. Caprioglio / Venice-Mestre, Italy* - V.Y. Reddy / New York, USA*

• LAA closure with Watchman device: procedure and outcomes

F. Ronco / Venice-Mestre, Italy*

• LAA closure with other endocardial plugs: technique and device selection, outcomes

H. Sievert / Frankfurt, Germany*

• Percutaneous epicardial approaches for LAA closure

C. Ellis / Nashville, USA

• LAA treatment for HNT control: does occlusion vs exclusion matter?

R. Gopinathannair / Overland Park, USA


SymposiumAF & HF: RECENT ADVANCES IN THERAPYChairs: S. Lévy / Marseille, France -R. Valle / Chioggia, Italy

• Prevalence and signifi cance of AF in HF with reduced and preserved EF


• Medical drug therapy: which role today? A. Capucci / Ancona, Italy

• After ATAAC and CASTLE-AF, should AF catheter ablation be labeled as class I indication?

N.F. Marrouche / Salt Lake City, USA

• Biventricular/HB pace-and-ablate: when, who, and why?

M. Grimaldi / Acquaviva delle Fonti, Italy

* To be confi rmed


34


Saturday 5 October / 10.15-11.45

EURA - VA Joint SessionHYBRID APPROACH TO AF TREATMENTChairs: L. Santini / Rome, Italy - V. Snezhitskiy / Grodno, Belarus

• Risk factors and outcomes predictors of AF: the role of hypertension

M. Dzeshka / Grodno, Belarus

• First in man trial of low energy multistage electrotherapy of AF

I. Efi mov / Washington, USA

• Structure based approach to treat AF patients

A. Ardashev / Moscow, Russia

• Endocardial left ventricular pacing for cardiac resynchronization in AF hybrid therapy

Y.I. Karpenko / Odessa, Ukraine


RSSA - VA Joint SessionNOVEL APPROACH TO THE HYBRID TREATMENT OF PERSISTENT ATRIAL FIBRILLATIONChairs: S. Benussi / Brescia, Italy - D. Mangino / Venice-Mestre, Italy*

• Multi-stage approach to the treatment of AF

M. Castellá Pericás / Barcelona, Spain

• Clinical outcomes of a simultaneous hybrid procedure for persistent atrial fi brillation

B. Maesen / Maastricht, the Netherlands*

• Hybrid procedure for long-standing persistent atrial fi brillation

A. Revishvili / Moscow, Russia

• Is it possible to apply hybrid approach to Cox-Maze procedure?

J.L. Cox / Chicago, USA


APHRS - VA Joint SessionUPDATE IN NON-PV TRIGGERS IN AF ABLATION. WHEN IT IS INDICATED AND HOW TO AVOID COMPLICATIONSChairs: F. Gaita / Turin, Italy* -Y.H. Kim / Seoul, South Korea

• Superior vena cava S.A. Chen / Taipei, Taiwan

• Ligament of Marshall C. Hwang / Provo, USA

• Left atrial appendage A. Natale / Austin, USA

• Coronary sinus and posterior left atrial wall S. Themistoclakis / Venice-Mestre, Italy*


Korean HRS - VA Joint SessionAF ABLATION: NEW INNOVATIVE CONCEPTChairs: C. Hwang / Provo, USA - K.H. Kuck / Hamburg, Germany

• My approach for redo AF ablation Y.S. Oh / Seoul, South Korea

• Virtual AF computer model guided ablation of persistent AF

H.N. Pak / Seoul, South Korea

• Role of epicardial mapping in AF ablation Y.H. Kim / Seoul, South Korea

• Single-shot AF ablation C. Tondo / Milan, Italy

* To be confi rmed


35



36


37

Detailed Scientifi c ProgramConsiglio Room


38

Detailed Scientifi c Program Consiglio Room


Core CurriculumVALUE OF CARDIAC IMAGING IN THE ASSESSMENT OF SD RISK AND VT TREATMENTChairs: J.J. Bax / Leiden, the Netherlands - S. Iliceto / Padua, Italy

• Arrhythmogenic right ventricular cardiomyopathy

R.N.W. Hauer / Utrecht, the Netherlands

• Hypertrophic cardiomyopathy W.J. McKenna / Doha, Qatar*

• Non-ischemic cardiomyopathy J.F. Viles-Gonzalez / Miami, USA

• Three-dimensional architecture by MRI for VT management

A. Berruezo / Barcelona, Spain


Core CurriculumIMPROVING OUTCOME AND UNDERSTANDING OF FOCAL VT ABLATIONChairs: F.E. Marchlinski / Philadelphia, USA - K. Shivkumar / Los Angeles, USA*

• PVC induced cardiomiopathy: pathophysiology and ablation results

Y.M. Cha / Rochester, USA*

• Localization and cryoablation for papillary muscle PVCs

G.E. Supple / Philadelphia, USA

• Anatomy, mapping, ablation of LV Summit VT

F.C. Garcia / Philadelphia, USA

• How to interpret the change in PVC QRS complex with ablation

P. Santangeli / Philadelphia, USA


SymposiumHOW TO PREDICT AND PREVENT SUDDEN DEATH: PATIENTS WITHOUT STRUCTURAL HEART DISEASEChairs: G.L. Botto / Milan, Italy - K.H. Kuck / Hamburg, Germany*

• WPW syndrome D.G. Katritsis / Athens, Greece*

• Brugada syndrome G.B. Chierchia / Brussels, Belgium*

• Long QT syndrome P.G. Postema / Amsterdam, the

Netherlands*

• Early repolarization syndrome S. Viskin / Tel Aviv, Israel


SymposiumHOW TO PREDICT AND PREVENT SUDDEN DEATH: PATIENTS WITH STRUCTURAL HEART DISEASEChairs: A. Baranchuk / Kingston, Canada* -A. Raviele / Venice-Mestre, Italy

• Arrhythmogenic right ventricular cardiomyopathy

H. Calkins / Baltimore, USA

• Sarcoidosis H.N. Pak / Seoul, South Korea

• Mitral valve prolapse M. Perazzolo Marra / Padua, Italy

• Non-ischemic cardiomyopathy G.L. Botto / Milan, Italy

* To be confi rmed


39



ISHNE - VA Joint SessionHOW TO REDUCE THE RISK OF VT IN ICD PATIENTS?Chairs: R. Verlato / Camposampiero, Italy - J.F. Viles-Gonzalez / Miami, USA

• Pharmacological therapy in reducing risk of ventricular tachyarrhythmias

W. Zareba / Rochester, USA

• Role of ICD programming in reducing appropriate and inappropriate therapy

J.S. Steinberg / Short Hills, USA*

• Role of home ICD monitoring in reducing arrhythmia

N. Varma / Cleveland, USA

• Sympathetic denervation in highly arrhythmogenic patients

K. Shivkumar / Los Angeles, USA*


Featured SymposiumBRUGADA SYNDROME, AN ELECTRICAL DISEASE OR A CARDIOMYOPATHYChairs: S. Viskin / Tel Aviv, Israel - A.A. Wilde / Amsterdam, the Netherlands

• Genetics of Brugada syndrome V. Probst / Nantes, France*

• Repolarization abnormalities in Brugada syndrome

F. Migliore / Padua, Italy*

• The RVOT as a substrate for arrhythmias B.J. Boukens / Amsterdam, the

Netherlands

• Structural abnormalities in Brugada syndrome

C. De Asmundis / Brussels, Belgium


Core CurriculumEVOLVING STRATEGIES AND TECHNIQUES FOR VT MAPPING AND ABLATIONChairs: J. Bradfi eld / Los Angeles, USA - D.J. Callans / Philadelphia, USA

• Endo - EPI mapping and VT circuits: observations and clinical implications

A. Dello Russo / Milan, Italy*

• Lesson learned from needle electrode ablation

W.G. Stevenson / Nashville, USA

• Mapping and ablation in the OR and with LVAD insertion

W. Tzou / Aurora, USA

• Mapping and ablation in Brugada syndrome - technique and endpoints

C. Pappone / San Donato Milanese, Italy*


Taiwan HRS - VA Joint SessionVENTRICULAR ARRHYTHMIA IN WEST AND NON-WESTChairs: S.A. Chen / Taipei, Taiwan - A. Natale / Austin, USA

• VT in ischemic and nonischemic cardiomyopathy: similar and different

P. China / Venice-Mestre, Italy*

• Planner epicardial wavelet propagation in Brugada syndrome: role of ILAM

F.P. Chung / Taipei, Taiwan

• Prevention of early mortality after ablation for an electrical storm: who, when, and how?

P. Santangeli / Philadelphia, USA

• Prevention of VT/VF-associated out-of-hospital cardiac arrest: lessons from Taichung Sudden Unexpected Death Registry (THUNDER)

K.C. Chang / Taichung, Taiwan

* To be confi rmed


40



Featured SymposiumQUINIDINE THERAPY: BACK FROM EXILE!Chairs: A. Capucci / Ancona, Italy* -M.F. Márquez / Mexico City, Mexico*

• VF as a Purkinje disease M. Hocini / Bordeaux, France*

• Why quinidine works in idiopathic VF A.A. Wilde / Amsterdam, the Netherlands

• Torsade de pointes treated with quinidine S. Viskin / Tel Aviv, Israel

• New indications for quinidine therapy R. Rosso / Tel Aviv, Israel


Mexican CornerCHANNELOPATHIES IN 2018. GENETICS AND BEYONDChairs: L. Colín-Lizalde / Mexico City, Mexico - M.F. Márquez / Mexico City, Mexico

• Genetic testing in sudden cardiac death: to do or not to do?

A. Medeiros-Domingo / Dübendorf, Switzerland

• Dysfunction of the NaV1.5-Kir2.1 channelosome in the mechanism of inheritable cardiac arrhythmias

J. Jalife / Ann Arbor, USA

• Controversies in automatic implantable defi brillators in congenital cardiac sudden death syndromes

L. Molina / Mexico City, Mexico

• Arrhythmias in Brugada syndrome. Not everything is ventricular tachycardia

J. Gómez-Flores / Mexico City, Mexico


Featured SymposiumLONG QT SYNDROME: UN UPDATEChairs: E. Behr / London, UK* -V. Probst / Nantes, France*

• LQTS, what is a long QT interval? P.G. Postema / Amsterdam, the Netherlands

• LQTS, risk stratifi cation C. Napolitano / Pavia, Italy*

• LQTS, should everyone be treated? S. Kääb / Munich, Germany

• LQTS, new therapeutic options P.J. Schwartz / Milan, Italy


Featured SymposiumARRHYTHMOGENIC CARDIOMYOPATHY: WHAT’S NEW?Chairs: C. Basso / Padua, Italy - S. Saksena / New Brunswick, USA*

• The new ACM consensus document W.G. McKenna / Doha, Qatar*

• ARVC, new insights in its pathophysiology E. van Rooij / Utrecht, the Netherlands*

• HCM, new insights in its pathophysiology F. Cecchi / Florence, Italy*

• New therapy in ACM R.N.W. Hauer / Utrecht, the Netherlands*

* To be confi rmed


41



42


43

Detailed Scientifi c Program Cipressi Room


44



WSA – VA Joint SessionDEVICES RECALLS. WHAT TO DOChairs: C. Love / Baltimore, USA* -S. Zhang / Beijing, China

• Manufactures reports and real life data in follow up

J.N. Catanzaro / Jacksonville, USA*

• When and who inform the patients T.F. Deering / Atlanta, USA*

• Who should establish the reaction after a recall?

R.P. Ricci / Rome, Italy*

• When more is worse than less in reaction to a recall

O. Oseroff / Buenos Aires, Argentina


Core CurriculumREMOTE MONITORING: CURRENT GUIDELINES, VALUE IN SPECIAL CLINICAL SETTINGS, FUTURE PERSPECTIVESChairs: S. Mittal / New York, USA - R.P. Ricci / Rome, Italy

• Current guidelines for remote monitoring of implantable cardiac device

G. Zanotto / Legnago, Italy

• Utility and limitations of implantable loop recorders in patients with atrial fi brillation

R.S. Passman / Chicago, USA

• Remote monitoring in heart failure patients: value or hype?

A. D’Onofrio / Naples, Italy

• Future directions in remote monitoring J.P. Piccini / DUrham, USA*


Featured SymposiumLEAD EXTRACTION AND DEVICE INFECTION: TECHNICAL AND PRACTICAL ASPECTSChairs: M.G. Bongiorni / Pisa, Italy - A. Kutarski / Lublin, Poland

• Pediatric lead extraction F. Drago / Rome, Italy

• Extracting leadless devices C.A. Rinaldi / London, UK*

• Imaging techniques in lead extraction S. Hakmi / Hamburg, Germany

• Optimizing safety in lead extraction by selecting the most suitable approach, tool and technique

P. Defaye / Grenoble, France


Featured SymposiumLEAD EXTRACION AND DEVICE INFECTION: NOVEL ASPECTSChairs: J.C. Deharo / Marseille, France - C. Kennergren / Gothenburg, Sweden

• CIED and infections: what’s new? S. Mittal / New York, USA*

• Superfl uous lead: to extract or not to extract in the new era?

L. Segreti / Pisa, Italy

• Prevention and treatment of complications: new strategies

J.N. Catanzaro / Jacksonville, USA*

• Risk scores to predict diffi culties and complications

F. Regoli / Lugano, Switzerland

* To be confi rmed


45



Featured SymposiumNOVEL PACING STRATEGIES TO TREAT ARRHYTHMIAS AND HEART FAILUREChairs: M. Gasparini / Rozzano, Italy* -T. Lewalter / Munich, Germany

• Leadless pacing of the right ventricle and the atrium

W. Jung / Villingen-Schwenningen, Germany

• Left ventricular leadless pacing M.G. Bongiorni / Pisa, Italy*

• Who should receive cardiac contractility modulation?

K.H. Kuck / Hamburg, Germany

• His bundle pacing for CRT P. Vijayaraman / Wilkes-Barre, USA


ISHNE - VA Joint SessionTELEMEDICINE IN CARDIAC ARRHYTHMIASChairs: H. Calkins / Baltimore, USA - M. Lunati / Milan, Italy

• Digital health and mobile medical applications: clinician perspective

N. Varma / Cleveland, USA

• Implications of AF detected on wearable monitors

TBD

• Arrhythmia burden as endpoint in clinical trials

W. Zareba / Rochester, USA

• How long ECG monitoring should be used? E.T. Locati / Milan, Italy


Featured SymposiumCONTROVERSIAL INDICATIONS FOR CRTChairs: A.E. Epstein / Philadelphia, USA - W. Jung / Villingen-Schwenningen, Germany

• CRT in right bundle branch block M.R. Gold / Charleston, USA

• CRT in patients with atrial fi brillation M. Gasparini / Rozzano, Italy*

• CRT for heart block with EF > 40% M. Zecchin / Trieste, Italy

• CRT in HF with preserved EF and left bundle branch block

R.C. Canby / Austin, USA*

* To be confi rmed


46



SymposiumCONTROVERSIAL ISSUES IN CLINICAL PACING: SHOULD I, WHEN SHOULD...Chairs: A.E. Epstein / Philadelphia, USA - M. Lunati / Milan, Italy

• When should I implant a pacemaker in patients with vasovagal syncope?

A. Corrado / Venice-Mestre, Italy*

• Should I treat with a pacemaker patients with syncope, bundle branch block, and negative EPS?

M. Santini / Rome, Italy

• Should all patients with a CRT CIED and AF have their AV junctions ablated?

J.S. Steinberg / Short Hills, USA*

• When should a leadless pacemaker be implanted in patients with sinus rhythm?

V.Y. Reddy / New York, USA*


Featured SymposiumNON-RESPONSE TO CRTChairs: A. Proclemer / Udine, Italy -A.M. Russo / Camden, USA*

• AF ablation M. Hocini / Bordeaux, France*

• Frequent ventricular extrasystoles A. Rossillo / Vicenza, Italy

• Mitral regurgitation J.J. Bax / Leiden, the Netherlands

• LV lead placement M.R. Gold / Charleston, USA


Core CurriculumHIS BUNDLE PACING: THE FASCINATING ROLE OF PHYSIOLOGY IN CARDIAC PACINGChairs: P. Vijayaraman / Wilkes-Barre, USA - F. Zanon / Rovigo, Italy

• His bundle pacing - Implant techniques: tips and tricks in clinical practice

G. Dandamudi / Indianapolis, USA

• His bundle pacing and AV node ablation P.S. Sharma / Chicago, USA

• Can His bundle pacing be the primary option for cardiac resynchronization therapy?

Z.I. Whinnett / London, UK

• His bundle pacing: programming and troubleshooting

S. Mittal / New York, USA

* To be confi rmed


47



48


49

Detailed Scientifi c Program Capriate Room


50



SymposiumHOW DOES ADVANCED AGE IMPACT CARE?Chairs: H. Calkins / Baltimore, USA - W.K. Shen / Phoenix, USA

• Management of AF in the elderly: drugs, ablation, or AVJ ablation

J.P. Piccini / Durham, USA*

• Evaluation and management of syncope in the elderly: what do the Guidelines tell us

D.G. Benditt / Minneapolis, USA

• Pacemakers in the elderly: when is a leadless PPM the right answer?

Y.M. Cha / Rochester, USA*

• Special considerations for ICD implantation in the elderly: what do we need to know?

C. Love / Baltimore, USA

• Anticoagulation considerations in the elderly: when is watchman the right answer?

G. Grassi / Venice, Italy


HRS - VA Joint SessionCONTROVERSIES IN ARRHYTHMIA THERAPY: WHAT ARE THE KNOWLEDGE GAPS?Chairs: C.M. Albert / Boston, USA - A.B. Curtis / Buffalo, USA

• Ablation in young asymptomatic WPW patients: prudent practice or cowboy cardiology?

K.H. Kuck / Hamburg, Germany*

• Non-ischemic cardiomyopathy, chronic heart failure, LVEF <35% and LBBB: CRT-D vs. CRT-P?

T.F. Deering / Atlanta, USA

• Should His bundle pacing be considered as an alternative to biventricular pacing in patients with AV block and LVEF <35%?

M.R. Gold / Charleston, USA


Core CurriculumLAA: ITS ROLE IN AF MAINTENANCE AND THROMBUS FORMATION Chairs: T. Lewalter / Munich, Germany* -H. Sievert / Frankfurt, Germany*

• Left atrial appendage as a cause for AF: what is the evidence?

D.R. Lakkireddy / Kansas City, USA*

• Left atrial appendage isolation for persistent AF: why, when, and how?

J. Romero / New York, USA

• Left atrial appendage anatomy: what you need to know for closure

J.S. Bradfi eld / Los Angeles, USA

• Patient selection for LAA closure M. Barbierato / Venice-Mestre, Italy*


Brazilian CornerHOT TOPICS IN 2019... AND STILL CONTROVERSIAL! WHAT IS THE MOST RECENT EVIDENCE?Chairs: E. Saad / Rio de Janeiro, Brazil - M. Scanavacca / São Paulo, Brazil

• Persistent AF should be approached with more extensive ablation than just PVI

Pros: L. Di Biase / New York, USA Cons: A. Verma / Newmarket, Canada

• LAA occlusion should be fi rst line in patients at high bleeding risk and AF

Pros: D.R. Lakkireddy / Kansas City, USA* Cons: J.M. Mandrola / Louisville, USA

• Epicardial mapping should be performed in every NICM VT ablation

Pros: F.P. Chung / Taipei, Taiwan Cons: F.E. Marchlinski / Philadelphia, USA

• His bundle pacing should be the preferred pacing modality in HF patients

Pros: F. Zanon / Rovigo, Italy Cons: J.J. Blanc / Brest, France*

* To be confi rmed


51



SymposiumAF-SCREEN INTERNATIONAL COLLABORATION SYMPOSIUMChairs: G. Boriani / Modena, Italy - L. Fauchier / Tours, France*

• We should recommend single time opportunistic screening for AF now

B. Freedman / Sydney, Australia

• Long term semi-continuous or short-term continuous screening for AF using wearables: Apple watches, or patches or both

M.P. Turakhia / Stanford, USA*

• What reservations should we have about widespread implementation of AF screening using wearables

C.M. Albert / Boston, USA*

• Searching for AF post stroke – the AF-SCREEN white paper

R. Bonin-Schnabel / Hamburg, Germany*


MENA HRS - VA Joint SessionCHALLENGING CASES IN ABLATION OF CARDIAC ARRHYTHMIASChairs: A. Al-Ahmad / Austin, USA - M. Refaat / Beirut, Lebanon

• Cryoballoon versus radiofrequency catheter ablation in atrial fi brillation?

TBD

• Challenging cases in outfl ow PVC/VT ablation

N. Asaad / Doha, Qatar*

• Challenging cases in SVT ablation TBD

• Challenging cases in accessory pathway ablation

M. Aboulmaaty / Cairo, Egypt

• Anatomical ablation strategy for noninducible fascicular tachycardia

A.K. Talib / Tsukuba, Japan

• Asymptomatic paroxysmal atrial fi brillation (<24-hour duration) detected by a cardiac implantable electronic device: should anticoagulation be prescribed?

A.M. Russo / Camden, USA

• Asymptomatic paroxysmal atrial fi brillation in patients over 65 years: ablation vs. medical therapy?

D.L. Packer / Rochester, USA


ECAS - VA Joint SessionCURRENT STATUS OF RECENTLY INTRODUCED THERAPIES FOR CARDIAC ARRHYTHMIAS MANAGEMENT Chairs: A.B. Curtis / Buffalo, USA* -A. Rossillo / Vicenza, Italy

• High density mapping for atrial fi brillation ablation: did it change outcomes?

M. Zardini / Parma, Italy*

• S-ICD therapy 10-years after introduction N. Pérez-Castellano / Madrid, Spain*

• Deliverable pacemakers: more risk than benefi t?

M.G. Bongiorni / Pisa, Italy

• NOACS for patient protection in various clinical conditions. Does dose selection matter?

R. Cappato / Rozzano, Italy

* To be confi rmed


52



Practical SessionVALUE OF SURFACE ECG IN THE INTERPRETATION OF CARDIAC ARRHYTHMIAS IN 2019: BACK TO THE FUTURE?“IN MEMORIAM OF LUIGI PADELETTI”Chairs: S. Boveda / Toulouse, France - R. De Ponti / Varese, Italy

• A rational approach to surface ECG A. Baranchuk / Kingston, Canada

• Challenges in narrow QRS complex tachycardia F.M. Leonelli / Tampa, USA

• Challenges in wide QRS complex tachycardia D.G. Della Rocca / Austin, USA

• When surface ECG orients invasive EP study R. Marazzi / Varese, Italy

Discussants: G. Bagliani / Foligno, Italy L. Calò / Rome, Italy S. Lévy / Marseille, France* M.F. Márquez / Mexico City, Mexico A. Raviele / Venice-Mestre, Italy M.M. Scheinman / San Francisco, USA G. Zuin / Venice-Mestre, Italy*


Practical SessionMECHANISM AND MANAGEMENT OF SUPRAVENTRICULAR ARRHYTHMIASChairs: M.M. Scheinman / San Francisco, USA - W.G. Stevenson / Nashville, USA

• Basic mechanisms of cardiac arrhythmias J. Jalife / Ann Arbor, USA*

• Principles of entrainment A.L. Waldo / Cleveland, USA

• Mechanisms and laboratory diagnoses of supraventricular tachycardia

G.F. Michaud / Nashville, USA

• Mechanisms and ablation of atrial fi brillation

A. Natale / Austin, USA


Practical SessionCLINICAL CASES: WHEN A PROCEDURE BECOMES A NIGHTMARE - SESSION 1Chairs: D.J Callans / Philadelphia, USA - A. Rossillo / Vicenza, Italy

• Case 1: Complex Koch’s triangle SVT Presenter: M. Scaglione / Asti, Italy* Discussant: D.G. Katritsis / Athens, Greece*

• Case 2: Septal accessory pathway Presenter: M. Tritto / Castellanza, Italy Discussant: A. Verma / Newmarket, Canada

• Case 3: Coronary sinus / Non coronary cusp atrial tachycardia

Presenter: F. Ouyang / Hamburg, Germany* Discussant: C. Tondo / Milan, Italy

• Case 4: Diffi cult transeptal puncture Presenter: W. Tzou / Aurora, USA Discussant: J. Sanchez / Austin, USA


Practical SessionCLINICAL CASES: WHEN A PROCEDURE BECOMES A NIGHTMARE - SESSION 2 Chairs: A. Bonso / Feltre, Italy - L. Di Biase / New York, USA

• Case 1: Papillary muscle VT Presenter: F.C. Garcia / Philadelphia, USA Discussant: A. Natale / Austin, USA

• Case 2: LV Summit VT Presenter: P. Santangeli / Philadelphia, USA Discussant: W.G. Stevenson / Nashville, USA*

• Case 3: Electrical storm Presenter: E. Anter / Boston, USA* Discussant: A. Berruezo / Barcelona, Spain

• Case 4: Epicardial VT Presenter: C. Carbucicchio / Milan, Italy* Discussant: M. Scanavacca / São Paulo, Brazil

* To be confi rmed


53



Practical SessionMECHANISM AND MANAGEMENT OF VT AND AV BLOCKChairs: G.F. Michaud / Nashville, USA - A.L. Waldo / Cleveland, USA

• Novel genetic mechanisms and ablation of VT

H.H. Hsia / San Francisco, USA

• Mechanisms and ablation of fascicular VT M.M. Scheinman / San Francisco, USA

• Mechanisms and ablation of ischemic VT W.G. Stevenson / Nashville, USA

• Pathophysiology and newer treatment for AV block

M. Brignole / Lavagna, Italy


54


55

Detailed Scientifi c ProgramPhotographs Room


56

Detailed Scientifi c Program Photographs Room


Core CurriculumPUBLISHED AND UNGOING CLINICAL TRIALS IN CARDIAC ARRHYTHMIASChairs: L. Di Biase / New York, USA - S. Themistoclakis / Venice-Mestre, Italy

• CASTLE AF N.F. Marrouche / Salt Lake City, USA

• CABANA D.L. Packer / Rochester, USA

• OCEAN A. Verma / Newmarket, Canada

• RESET CRT / DANISH TBD


Featured SymposiumVASOVAGAL SYNCOPE: MECHANISMSChairs: D. Hachul / São Paulo, Brazil - R. Sutton / Monte Carlo, Principality of Monaco*

• Do we really understand vasovagal syncope? What is left to learn?

J.C. Deharo / Marseille, France

• Neuro-humoral changes in VVS: triggers or bystanders?

A. Fedorowski / Malmö, Sweden

• Are women more susceptible to VVS than men? If so, why?

P. Alboni / Ferrara, Italy

• Testing for vasodepressor susceptibility: is it needed in all forms of refl ex syncope and how reproducible is the testing?

R. Sutton / Monte Carlo, Principality of Monaco


French CornerCARDIAC FIBROSIS AND ARRHYTHMIAS: FROM CELLS TO PATIENTSChairs: E. Aliot / Vandoeuvre-lès-Nancy, France - J.J. Blanc / Brest, France

• Cardiac fi brosis: pathophysiology and clinical consequences

S.N. Hatem / Paris, France

• Evaluation of cardiac fi brosis: value of morphologic and other markers

N.F. Marrouche / Salt Lake City, USA*

• Arrhythmic and prognostic implications of cardiac fi brosis

C. Piorkowski / Dresden, Germany

• Endurance training and cardiac fi brosis: risks and benefi ts

F. Schnell / Rennes, France*


Spanish CornerNEW CHALLENGES IN AF ABLATIONChairs: J.M. Almendral / Madrid, Spain -J. Osca Asensi / Valencia, Spain*

• Epicardial connections between atrial and pulmonary veins: prevalence and implications for ablation

M.T. Barrio-López / Madrid, Spain*

• Left atrial fl utter concomitant with AF: clinical implications

J. Jiménez-Candil / Salamanca, Spain*

• Rotor identifi cation and ablation in AF D. Calvo Cuervo / Oviedo, Spain*

• Laser ablation of the pulmonary veins J. Osca Asensi / Valencia, Spain*

* To be confi rmed


57



Featured SymposiumSYNCOPE IN THE YOUNG AND IN THE ELDERLY: PECULIAR ASPECTSChairs: A. Raviele / Venice-Mestre, Italy - W.K. Shen / Phoenix, USA*

• Solitary collapse episode in young patients with suspected channelopathy: what’s the next step?

D. Corrado / Padua, Italy*

• Which younger patient with recurrent asystolic syncope is a candidate for a pacemaker?


• Causes of syncope/collapse in the extreme elderly: novel approaches to diagnosis

S. Parry / Newcastle-upon-Tyne, UK

• Assessing and preventing progressive cognitive impairment and falls in older patients with symptomatic orthostatic hypotension

R.A. Kenny / Dublin, Ireland


Featured SymposiumSYNCOPE UNITS AND BEYONDChairs: S. Feigofsky / Carroll, USA - R.A. Kenny / Dublin, Ireland

• Should syncope units become the standard of care?

R.S. Sheldon / Calgary, Canada*

• Clinical decision making in syncope patient care: individualized or programmatic?

M.H. Hamdan / Madison, USA

• Syncope in the emergency department - What next steps can improve care?

R. Furlan / Rozzano, Italy

• The changing pattern of hospital admission in USA for syncope/collapse

D.G. Benditt / Minneapolis, USA


Featured SymposiumVASOVAGAL SYNCOPE: THERAPYChairs: B. Olshansky / Iowa City, USA -TBD

• How often is refl ex syncope the cause of collapse in patients with structural heart disease? Does it affect management?

C.A. Morillo / Calgary, Canada

• Pharmacological management of VVS: The Good, Bad and Ugly. (Discuss why there is a placebo effect)

R.S. Sheldon / Calgary, Canada

• Treatment of VVS: does it depend on age? Should it be individualized?

A. Ungar / Florence, Italy

• Vasovagal syncope ablation is ready for prime time

1. YES! J.C. Pachon / São Paulo, Brazil 2. NO! M. Brignole / Lavagna, Italy


Featured SymposiumSYNCOPE DUE TO AUTONOMIC DYSFUNCTION / DIFFERENTIATING SYNCOPE FROM SEIZUREChairs: C.A. Morillo / Calgary, Canada - S. Parry / Newcastle-upon-Tyne, UK

• Early heart rate and blood pressure changes during movement to upright posture: a tool to predict autonomic failure, neurogenic orthostatic hypotension and VVS susceptibility?

J.G. van Dijk / Leiden, the Netherlands

• Primary and secondary POTS: how to distinguish and treat

A. Cutolo / Venice-Mestre, Italy*

• Managing syncope due to orthostatic intolerance in a patient with supine hypertension

J.J. Blanc / Brest, France

• Recognizing and managing suspected seizure disorders: is there a role for implanted monitors?

M. Brignole / Lavagna, Italy

* To be confi rmed


58



Argentinean CornerSUDDEN DEATH AND ICDS: A REGIONAL EVALUATIONChairs: R. Cappato / Rozzano, Italy* -R.A. Sansalone / Buenos Aires, Argentina

• Sudden death and ICDs in South America O. Oseroff / Buenos Aires, Argentina

• Sudden death and ICDs in Europe M. Santini / Rome, Italy*

• Sudden death and ICDs in North America W. Zareba / Rochester, USA*

• Sudden death and ICDs in Asia Pacifi c F.P. Chung / Taipei, Taiwan*


Core Curriculum CARDIOVASCULAR ASSESSMENT OF SD RISK IN YOUNG ATHLETESChairs: A. Baranchuk / Kingston, Canada - U. Berrettini / Camerino, Italy

• The revised ESC recommendations for the interpretation of ECG in athletes

S. Sharma / London, UK

• Clinical interpretation of ventricular ectopic beats in athletes

D. Corrado / Padua, Italy

• Electrical markers of high risk in athletes A. Berruezo / Barcelona, Spain*

• External and implantable devices for prolonged ECG monitoring

F. Giada / Noale, Italy


Featured SymposiumLET’S DISCUSS TOGETHER: CURRENT GUIDELINES, DIFFICULTY CASES, AND FUTURE PERSPECTIVESChairs: P. Alboni / Ferrara, Italy - R.S. Sheldon / Calgary, Canada

• Key differences between US and European Syncope Guidelines: vive la difference?

W.K. Shen / Phoenix, USA

• Case 1 Young woman collapsed while getting

out of boat and swimming 20-30 meters to shore after docking her boat at a buoy during sailing competition

J.C. Deharo / Marseille, France

• Case 2 50 yo female prior athlete with recurrent

syncope and on one occasion fell out of a kayak. She had a normal heart but scar on MRI in the inferior wall. She got a life vest

B. Olshansky / Iowa City, USA

• Case 3 An 18 yo NCAA Level 1 College freshman

volleyball player is referred for multiple prolonged collapse events that started within the last several months but occur multiple times per week. Witnesses say she collapses abruptly, even while sitting on the bench or during practice and is unresponsive for 5 to 10 minutes without shaking. She has no past history of similar problems

M. Silvano / Venice-Mestre, Italy*

• Case 4 72 yo male with moderate aortic stenosis

and prior stents for 2 vessel CAD, ejection fraction 40% collapses while stepping out of the shower. Had similar collapse 3 years earlier while walking up a hill to get his mail

S. Feigofsky / Carroll, USA

• Syncope: where do we go from here? B. Olshansky / Iowa City, USA

* To be confi rmed


59



Core Curriculum UPDATES IN SPORTS CARDIOLOGYChairs: F. Giada / Noale, Italy - S. Sharma / London, UK

• Causes of sudden cardiac death in athletes: what’s new?

C. Basso / Padua, Italy

• The role of cardiac imaging in sports cardiology

B.K. Velthuis / Utrecht, the Netherlands

• ESC recommendations for athletes with cardiomyopathy

A. Pelliccia / Rome, Italy

• Cardiac arrest in the athletes: the myth of tongue swallowing

D. Viskin / Tel Aviv, Israel


60


61

Registration, Hotel & Practical Information


62

Scientifi c Secretariat Antonio Rossillo, MD Department of Cardiology, Ospedale San Bortolo, Vicenza, Italye-mail: [email protected]

Abstract guidelines and online submissionAbstracts can only be submitted electronically via the Abstract Submission System available at www.venicearrhythmias.orgDeadline: April 30th, 2019. Abstracts submitted after the deadline might not be accepted. Detailed information for authors submitting abstracts can be found at www.venicearrhythmias.org/abstract_submissionAll accepted abstracts (oral communications and posters) will be published in a special online issue of a prestigious international scientifi c journal after the event.

QuestionsIf you have any questions regarding the submission process, please contact us atscientifi [email protected]

AcceptanceNotifi cation of Acceptance/Non-acceptance: announcements will be e-mailed by May 30th, 2019.

Registration of abstract presentersAbstract presenters are required to register for the Scientifi c Sessions by June 18th, 2019. Expenses associated with the submission and presentation of an abstract are the responsibility of the presenter. The person inserted in the online form as “Presenting Author” will be considered the presenter.

If the registration is not accomplished within the scheduled time, the abstract will not be included in the special online journal issue.

SlidesOnly PC data projection will be available in every room. All slides must be worded in English only; please copy your work - prepared in PowerPoint - on a CD or USB pen. The Speaker Ready Room will be available for presenters and speakers to preview their slides and to become familiar with the audiovisual equipment. The use of personal laptops in the Workshop rooms is not allowed.

PostersAll posters must be prepared with dimension “portrait” 70cm width x 100cm height. Specifi c instructions about mantling, display and dismantling will be e-mailed in due time.

Offi cial languageThe offi cial language of the Workshop is ENGLISH. No translation will be provided during the scientifi c sessions except for the Allied Professionals Program.

Visa/international attendee informationIn addition to a passport, most internationalparticipants will need a Visa. It is advisableto contact the Italian Embassy or Consulateregarding Visa and Health Certifi caterequirements in your country of residence.The Organizing Secretariat is available to sendyou a Letter of Invitation for Visa Purposes. The invitation is meant to help participants obtaining a Visa, and is not a commitment on the part of the organizers to provide any fi nancial support.The decision to grant a Visa belongs to the Embassy/Consulate.


Scientifi c Information


63

Opening CeremonyThursday, October 3rd, 2019 - included in the registration fee.The Workshop will be inaugurated by the Congress Presidents, by Representativesof the Italian and International Scientifi c Societies and Study Groups that have granted their patronage, by the City Mayor and other Authorities.

Best Abstract AwardsThursday, October 3rd, 2019Venice Arrhythmias 2019 will give two special awards in Euro to those authors who have presented the “Best Oral Communication” and the “Best Poster”. An Abstract Award Committee will select the best work among the accepted oral communications and posters. The winners will be announced during the Opening Ceremony.

Raffaella Pieri Breakthrough Communication AwardThursday, October 3rd, 2019The VA 2019 Organizing Committee has decided to continue the “Raffaella Pieri Breakthrough Communication Award” to be given to the most cutting-edge communication message presented by VA 2019 exhibitors in terms of strength, effi cacy and innovative power. This award was established in memory of Ms. Raffaella Pieri, in appreciation for her outstanding contribution over many years in managing the relations with Venice Arrhythmias’ exhibitors and supporting companies on behalf of the Organizing Secretariat, and for her ever-helpful approach and highly missed sensibility. The award winner will receive a plaque, and a charitable donation to a primary cancer research foundation will be made in their name.

ADRIA CONGREX Srl via Sassonia 30 - 47922 Rimini - Italy

General information: ph +39 0541 305 822 / +39 0541 305 811fax +39 0541 [email protected] www.venicearrhythmias.org

Project Leader: Rita [email protected]

Scientifi c Information: Valentina Zanottiscientifi [email protected]

Exhibition & Industry: Lucia [email protected]

Registrations & Housing: Silvana [email protected]

During the Workshop the Organizing Secretariat will be at the Fondazione Giorgio Cini to provide all necessary assistance to VA 2019 participants.


Special events Organizing Secretariat


64

The Fondazione Giorgio Cini is located on the Island of San Giorgio Maggiore, right in front of St. Mark’s Square, in the heart of Venice.

ACTV public waterbus no. 2 takes you directly to the Island of San Giorgio Maggiore. It is just 1 stop away from San Zaccaria (near St. Mark’s Square). Approximate duration of the journey: From San Zaccaria: 3 minutes From Tronchetto: 25 minutes From Piazzale Roma: 35 minutesFrom Santa Lucia Railway station: 45 minutes

From Marco Polo Airport:Venice has a modern airport situated in the mainland at Venice-Tessera.You may choose among the following transportation options:• ATVO Line no. 35: bus service to Piazzale Roma, 20-minute journey, one-way ticket € 8,00• Alilaguna service: blue and red motor boat lines to San Marco Square,

60-minute journey, one-way ticket € 15,00• private water taxi to your hotel, 45-minute journey, one-way ticket € 110,00

From Venice Santa Lucia Railway Station:Venice has two railway stations: Venice-Mestre and Venice Santa Lucia. From Venice Santa Lucia station you can use the ACTV waterbuses that offer different transportation schedules all day long. Private taxis are available at the main exit of the station.

From A4 Motorway exit:Follow the indications to Venice parking areas of Tronchetto and/or Piazzale Roma where you can fi nd a variety of parking lots. From there, you can reach San Marco Square by waterbus no. 2.


How to reach the congress venue Fondazione Giorgio Cini

FONDAZIONE GIORGIO CINI Isola San Giorgio Maggiore - 30124 Venice - Italyphone +39 041 5289900 - fax 39 041 5238540 - www.cini.it

H

Canal Grande

Canal Grande

Congress VenueFondazione Giorgio Cini

Venice Lido

San Marco

San Giorgio Maggiore

PiazzaleRoma

Tronchetto

Giudecca

Marco PoloAirport

StationSanta Lucia


65

The Registration Fee includes:• For Delegates and Presenters: attendance

to all scientifi c sessions (limited to seats availability)

• For Allied Professionals: attendance to Allied Professionals sessions only

• Entrance to the exhibition area• Attendance certifi cate• Badge and congress kit• Local transportation (ACTV scheduled

services)• 22% Italian VAT (tax)

** To be able to register as a Young Physician, you must be max. 40 years old. Proof of age (i.e. copy of your ID or passport) must be provided during the registration process. To be able to register as a Student, you will be required to send a proof of your status (i.e. copy of a valid student card).

Group pre-registrationIf you wish to register a group of more than 10 people, please contact theOrganizing Secretariat at [email protected] Hotel AccommodationAs October is considered peak tourist season in Venice, it is recommended to book in great advance and possibly within May 31st, 2019. The Organizing Secretariat will make all efforts to confi rm your reservation in the hotel

category of your choice; if not possible, an alternative proposal will be submitted for your approval. Venetian hotels have very few single rooms, therefore rooms for single occupancy (DSO) will be assigned once the single rooms are no longer available. The majority of the hotels pre-booked for Venice Arrhythmias are located in Venice, once they are fully booked, alternative hotels located in Venice Lido or Mestre might be assigned.

Confi rmation documents will be sent starting from July 31st, 2019.

Please note that hotels are listed per categories/rate ranges and rooms will be assigned according to availability on a ”fi rst-come, fi rst-served” basis.

Payment termsPayments accepted are: credit cards, cheques written on Italian Banks and Bank Transfer in Euro. All costs to transmitters’ charge. Please indicate clearly your name and Venice Arrhythmias 2019 on cheque/money orders; a copy of the payment is requested together with the registration and hotel accommodation forms.Registration and Hotel Accommodation will be confi rmed only on receipt of the relevant payments. The settlement is required to process your reservation.

Before April From May 1st up to From September 30th, 2019 September 2nd, 2019 3rd, 2019

Delegates € 800,00 € 900,00 € 1000,00

Young Physicians and Students** € 600,00 € 700,00 € 800,00 Allied Professionals € 100,00 € 110,00 € 120,00

Registration & Hotel


Registration Fees


66


Adria Congrex will issue a regular invoice for registration (22% VAT inclusive) andhotel accommodation (10% VAT inclusive); therefore the European VAT code(only for EU countries) is due to be included in the forms. Please note that VAT could be subject to changes. The VAT rate will be applied depending on the Italian fi scal law at the time of payment.

Cancellation termsAny cancellation should be notifi ed in writing to Adria Congrex and will besubject to the following conditions:Before July 31st, 2019.Refund of the registration and hotel

accommodation is subject to a 30%administrative charges. All refunds, if any, will be made after the congress (all costs to receivers’ charge).After August 1st, 2019.No refund of any kind.

Changes in programFor scientifi c and/or technical reasons the Scientifi c Committee, the Organizing Committee and the Secretariat reserve the right to make any change in the Workshop program.


67

Venice Hotel list


Hotel Venice Center CAT DSO (€) DBL (€)

1 All’Angelo 4 380,00 380,00

2 Al Ponte dei Sospiri 4 425,00 425,00

3 Aqua Palace 4 345,00 345,00

4 Boscolo Hotel Bellini 4 455,00 475,00

5 Ca’ dei Conti 4 335,00 350,00

6 Gabrielli 4 380,00 380,00

7 Palazzo Giovanelli 4 465,00 480,00

8 Palazzo Sant’Angelo 4 396,00 418,00

9 Papadopoli 4 320,00 350,00

10 Santa Marina 4 340,00 370,00

11 Sant’Elena 4 450,00 460,00

12 Savoia & Jolanda 4 410,00 410,00

13 Starhotels Splendid Venice 4 500,00 500,00

14 Ca’ Formenta 3 235,00 250,00

Hotel Venice Lido CAT DSO (€) DBL (€)

15 Russo Palace 4 205,00 215,00

16 Villa Laguna 4 199,00 199,00

17 Villa Mabapa 4 215,00 245,00

18 Villa Pannoia 4 180,00 200,00

CAT Star categoryDSO Double room for single occupancyDBL Double room

The rate is per day, per room, in Bed&Breakfast accommodation.

City tax is not included. The price of the City tax per day, per personand updated to November 2018 is:

Venice Centre 3 stars Hotel: € 3,50Venice Centre 4 stars Hotel: € 4,50Venice Lido 4 stars Hotel: € 3,60


68

Giudecca

San G

8

12

9

4

Train station

Accademia Gallery

Casino

Santa Mariadella Salute Church

St. Mark’s Square

Fondazione Giorgio Cini

6

1 52

133

7

10


69

n Giorgio

Venice Venice Lido

1715

1618

Venetian Arsenal

14

11


Notes


Notes


Mark Your Agenda!

June 18th, 2019Deadline for registration of abstract presenters

September 2nd, 2019Deadline for discountedregistration fee

April 30th, 2019Abstract submission deadline

May 30th, 2019Notifi cation of acceptance for oral communication and poster


Stay Tuned!

Find more about the Workshop:www.venicearrhythmias.orgDon’t miss the opportunity to receivethe latest news and informationabout the event!

Follow us on



Documents

VA2019PAdvPRG 0219.indd 2 05/04/19 15...Workshop to meet up and discuss the latest science, and innovations in clinical arrhythmology, cardiac electrophysiology and pacing. As in the